カテゴリー： 世界, Stratistics MRC

世界の臓器保存液市場（～2030年）

【英語タイトル】Organ Preservation Solution Market Forecasts to 2030

Stratistics MRCが出版した調査資料（SMRC24712）・商品コード：SMRC24712
・発行会社（調査会社）：Stratistics MRC
・発行日：2026年4月
・ページ数：200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル
・産業分野：医療・バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,150 ⇒換算￥664,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD5,250 ⇒換算￥840,000見積依頼/購入/質問フォーム
Corporate License（閲覧人数無制限）USD7,500 ⇒換算￥1,200,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Stratistics MRCによると、世界の臓器保存液市場は2026年に3億5,890万ドル規模となり、予測期間中は年平均成長率（CAGR）8.8％で拡大し、2034年には7億460万ドルに達すると見込まれています。臓器保存液は、提供から移植までの重要な期間において臓器の生存能力を維持する能力を有しており、移植医療に不可欠なものです。これらの特殊な保存液は、臓器を虚血性損傷から保護するように設計されており、理想的な保存環境を提供します。また、細胞の完全性を維持し、細胞の腫脹を防ぐ役割も果たします。

米国疾病予防管理センター（CDC）の2020年の推計によると、糖尿病の成人の3人に1人、高血圧の成人の5人に1人が慢性腎臓病を患っている可能性がある。2021年に発表されたCDCの報告書によると、米国では毎年約15％の人が慢性腎臓病に罹患している。

市場の動向：

推進要因：
臓器移植手術件数の増加
臓器不全を引き起こす慢性疾患の増加に加え、手術法の進歩や免疫抑制剤の改良により、世界の臓器移植率は止まることを知らない勢いで増加している。さらに、需要の高まりは、移植手術の成功と患者の生存にとって臓器保存ソリューションがいかに重要であるかを浮き彫りにしており、これがひいては、さまざまな種類の臓器に対応したソリューションの強化と最適化に向けた継続的な研究開発の取り組みを後押ししている。

制約要因：
既存の保存法の有効性の限界
この分野の進歩にもかかわらず、特に長期間にわたる保存の場合、一部の臓器については、現行の臓器保存法によって生存率が制限される可能性がある。臓器ごとの複雑さや固有の生理学的要件のため、普遍的に有効な解決策の開発は困難である。さらに、この制約に対処するためには、各臓器に固有の保存要件を包括的に把握し、現行の保存液の有効性を向上させるための継続的な研究が必要である。

機会：
凍結保存技術の進展
凍結保存技術が進化し続ける限り、臓器保存市場は成長すると予想される。凍結保護剤や凍結技術の進歩により、臓器保存期間の延長や長期保存の実現可能性の向上が可能となる。さらに、これにより臓器移植のスケジュール設定がより柔軟になり、物流管理の改善にもつながる。

脅威：
保存手順の標準化が不十分
臓器保存に関する確立された手順の欠如は、業界にとって障害やリスクとなっている。医療機関や地域によってプロトコルが異なると、情報共有が妨げられ、保存結果にばらつきが生じる恐れがある。さらに、臓器保存技術の信頼性と効率性を保証するためには、広く認められた基準の確立が不可欠である。

新型コロナウイルス（COVID-19）の影響：
臓器保存市場は、新型コロナウイルス（COVID-19）のパンデミックにより様々な影響を受けています。臓器移植の手順が影響を受け、その結果、移植件数が減少しました。これらの要因には、医療システムの混乱、物流上の困難、そしてパンデミック対策への優先順位のシフトなどが含まれます。ロックダウン、移動制限、医療へのアクセス制限により、臓器移植は阻害されてきた。さらに、医療予算や資源への財政的圧迫を受けて、臓器保存ソリューションの研究開発にも変化が見られている。

予測期間中、ウィスコンシン大学ソリューション（UW）セグメントが最大規模になると予想される

ウィスコンシン大学ソリューション（UW）セグメントが最大の市場シェアを占めると予測されている。腎臓、肝臓、膵臓の臓器移植では、極めて効果的で適応性の高い臓器保存液であるUWソリューションが頻繁に使用されている。その浸透圧、バランスの取れた電解質組成、および細胞浮腫を軽減する能力により、臓器採取から移植までの重要な期間における臓器保存の推奨選択肢となっている。さらに、その広範な普及は、移植の良好な成果、長年にわたる臨床使用の歴史、および臓器の生存率を維持してきた実績に起因している。

「専門クリニック」セグメントは、予測期間中に最も高いCAGRを示すと予想される

臓器保存市場は、専門クリニックにおいて最も高いCAGRで成長している。臓器移植および保存に特化した専門クリニックの成長は、より専門化された医療サービスへの傾向に加え、対象を絞った患者中心のケアに対する需要の高まりによって後押しされている。移植前の評価、臓器保存技術、移植後のケアは、これらのクリニックが提供する広範なサービスの一部に過ぎない。さらに、臓器不全の有病率の増加や移植技術の進歩に伴い、患者は専門クリニックの専門知識を求めており、こうしたクリニックは従来の病院よりも効率的で個別化されたケアを提供することが多い。

シェアが最大の地域：

臓器保存ソリューション市場において、北米が最大のシェアを占めています。この優位性には、整備された医療制度、臓器移植手術の頻度の高さ、医学および技術の継続的な進歩など、数多くの要因が寄与しています。さらに、同地域は、強固な規制環境、多額の研究開発費、そして最先端の医療ソリューションの積極的な導入により、業界の最前線に立っています。

CAGRが最も高い地域：

臓器保存ソリューション市場において、アジア太平洋地域は最も高いCAGRを記録している。臓器不全の有病率の増加、臓器移植に対する一般市民の意識の高まり、医療インフラの進展など、多くの要因がこの地域の急速な成長を牽引している。さらに、アジア太平洋地域における市場シェアの拡大は、医療ツーリズムへの注目度の高まりや、臓器保存技術の進歩にも起因している。

市場の主要企業

臓器保存ソリューション市場の主要企業には、Paragonix Technologies, Inc、Organox Limited、Transmedics, Inc.、Bridge to Life Ltd、Transplant Biomedicals、Accord Healthcare Inc.、Waters Medical Systems LLC、Preservation Solutions, Inc.、Xvivo Perfusion ABなどが挙げられる。

主な動向：

2023年8月、米国を拠点とする商業医療グループであるTransMedics Groupは、米国を代表するチャーター便運航会社であるSummit Aviationの完全買収を完了したと発表した。この買収により、TransMedics Aviationは、米国において臓器移植に特化した初の全国規模の統合型航空物流プロバイダーとしての地位を確立した。

2023年7月、Organox Ltd.は2,500万ポンドの資金調達ラウンドを実施した。同社執行会長のOern Stuge氏はBioWorldに対し、移植センターからの需要が大幅に増加していることを背景に、この資金により米国での事業拡大が可能になると語った。また、同氏は、移植用肝臓の保存・輸送システムを製造する英国オックスフォードに拠点を置く同社が、将来的にはナスダックへの上場も準備していると付け加えた。
2023年3月、臓器移植分野をリードするParagonix Technologies, Inc.は、Signet Healthcare Partnersが主導するシリーズB資金調達で2,400万ドルを確保したと発表した。この成長投資により、Paragonix Technologiesは、臨床サービスの提供範囲の継続的な拡大や在庫の拡充を含む事業基盤を強化し、移植技術の革新をさらに推進することが可能になる。

対象となるソリューション：
• ウィスコンシン大学ソリューション（UW）
• カストディオールHTKソリューション
• パーフェデックスソリューション
• スティーンソリューション
• セルシオールソリューション
• ハイポサーモソルソリューション
• その他のソリューション

対象となる保存方法：
• 静的低温保存
• 低体温機械灌流
• 常温機械灌流
• その他の保存方法

対象となる臓器：
• 腎臓
• 肝臓
• 肺
• 心臓
• その他の臓器

対象エンドユーザー：
• 臓器移植センター
• 病院
• 専門クリニック
• その他のエンドユーザー

対象地域：
• 北米
o 米国
o カナダ
o メキシコ
• ヨーロッパ
o ドイツ
o 英国
o イタリア
o フランス
o スペイン
o その他のヨーロッパ諸国
• アジア太平洋
o 日本

o 中国
o インド
o オーストラリア
o ニュージーランド
o 韓国
o アジア太平洋のその他の地域
• 南アメリカ
o アルゼンチン
o ブラジル
o チリ
o 南アメリカのその他の地域
• 中東・アフリカ
o サウジアラビア
o アラブ首長国連邦
o カタール
o 南アフリカ
o 中東・アフリカのその他の地域

According to Stratistics MRC, the Global Organ Preservation Solution Market is accounted for $358.9 million in 2026 and is expected to reach $704.6 million by 2034 growing at a CAGR of 8.8% during the forecast period. Organ Preservation Solution has the ability to preserve organ viability during the crucial time between donation and transplantation, organ preservation solutions are essential to transplant medicine. The ideal preservation environment is provided by these specialized solutions, which are made to shield organs from ischemia damage. These solutions aid in preserving cellular integrity and preventing cellular swelling.

According to the estimates by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. Per the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year.

Market Dynamics:

Driver:
Growing numbers of organ transplant operations
The world’s organ transplantation rate is increasing at an unstoppable rate due to an increase in chronic diseases that cause organ failure as well as improvements in surgical methods and immunosuppressive medications. Additionally, the growing demand highlights how vital organ preservation solutions are to the survival and success of transplant operations, which in turn drives ongoing research and development endeavors to enhance and optimize these solutions for a variety of organ kinds.

Restraint:
Limited effectiveness of existing preservation methods
The viability of some organs may be limited by some current organ preservation methods, even with advancements in the field, especially when done for prolonged periods of time. Developing universally effective solutions is challenging due to the complexity of various organs and their distinct physiological requirements. Furthermore, a comprehensive grasp of the preservation requirements unique to each organ and continuous research to improve the effectiveness of current formulations are necessary to address this constraint.

Opportunity:
Technological developments in cryopreservation
The organ preservation market is expected to grow as long as cryopreservation technology continues to progress. The prolongation of organ preservation periods and the enhancement of long-term storage feasibility can be possible through advancements in cryoprotectants and freezing techniques. Moreover, this can lead to more flexible organ transplant scheduling and improved logistical management.

Threat:
Inadequate standardization of preservation procedures
The lack of established procedures for organ preservation creates obstacles and risks for the industry. Disparate protocols among healthcare facilities and geographical areas could impede communication and lead to inconsistent preservation results. Additionally, the establishment of widely recognized standards is essential to guaranteeing the dependability and efficiency of organ preservation techniques.

Covid-19 Impact:
The market for organ preservation has seen a variety of effects from the COVID-19 pandemic. Organ transplantation procedures have been impacted, which has resulted in a decrease in transplant volumes. These factors include disruptions in healthcare systems, logistical difficulties, and a shift in priorities towards managing the pandemic. Organ transplantation has been hampered by lockdowns, travel restrictions, and limited access to healthcare. Furthermore, research and development for organ preservation solutions have also seen changes in response to the financial strain on healthcare budgets and resources.

The University of Wisconsin Solution (UW) segment is expected to be the largest during the forecast period

It is projected that the University of Wisconsin Solution (UW) segment will command the largest market share. Organ transplants for the kidney, liver, and pancreas are frequently performed using the UW solution, an extremely effective and adaptable organ preservation medium. Because of its osmotic pressure, balanced electrolyte composition, and capacity to reduce cellular edema, it is the recommended option for organ preservation during the crucial time between organ procurement and transplantation. Moreover, its broad acceptance can be attributed to its successful transplantation outcomes, long history of clinical use, and track record of preserving organ viability.

The Specialty Clinics segment is expected to have the highest CAGR during the forecast period

The market for organ preservation is growing at the highest CAGR in specialty clinics. The growth of specialty clinics devoted to organ transplantation and preservation is facilitated by the trend toward more specialized healthcare services as well as the rising need for targeted, patient-centered care. Pre-transplant evaluations, organ preservation techniques, and post-transplant care are just a few of the extensive services provided by these clinics. Additionally, patients are seeking the expertise of specialized clinics, which often offer more efficient and personalized care than traditional hospitals, due to the increasing prevalence of organ failure conditions and advancements in transplantation techniques.

Region with largest share:

In the market for organ preservation solutions, North America holds the largest share. Numerous factors contribute to this dominance, such as a well-developed healthcare system, a high frequency of organ transplant procedures, and ongoing advancements in medical science and technology. Furthermore, the region is at the forefront of the industry because of its strong regulatory environment, large R&D expenditure, and proactive adoption of cutting-edge healthcare solutions.

Region with highest CAGR:

In the market for organ preservation solutions, the Asia-Pacific region has the highest CAGR. A number of factors, including an increase in the prevalence of organ failure conditions, public awareness of organ transplantation, and advancements in healthcare infrastructure, are driving this region’s rapid growth. Furthermore, the growing market share in the Asia-Pacific region can be attributed to the growing emphasis on medical tourism as well as advancements in organ preservation techniques.

Key players in the market

Some of the key players in Organ Preservation Solution market include Paragonix Technologies, Inc, Organox Limited, Transmedics, Inc., Bridge to Life Ltd, Transplant Biomedicals, Accord Healthcare Inc., Waters Medical Systems LLC, Preservation Solutions, Inc. and Xvivo Perfusion AB.

Key Developments:

In August 2023, US-based commercial medical group TransMedics Group announced the completion of the full acquisition of Summit Aviation, a premier US charter flight operator. The acquisition establishes TransMedics Aviation as the first integrated national provider of air logistics dedicated exclusively to organ transplantation in the US.

In July 2023, Organox Ltd. raised £25 million in a funding round that will allow the company to expand its operations in the U.S. on the back of significantly increasing demand from transplant centers, Oern Stuge, executive chairman, at Organox told BioWorld. The Oxford, U.K.-based company which makes systems to preserve and transport livers for transplant is also preparing for its eventual listing on Nasdaq, he added.

In March 2023, Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by Signet Healthcare Partners. This growth investment will bolster Paragonix Technologies’ commercial footprint, including its ongoing extension of clinical service offerings and inventory expansion, and will enable the Company to further advance transplant innovations.

Solutions Covered:
• University of Wisconsin Solution (UW)
• Custodiol HTK Solution
• Perfadex Solution
• Steen Solution
• Celsior Solution
• Hypothermosol Solution
• Other Solutions

Preservation Types Covered:
• Static Cold Storage
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Other Preservation Types

Organs Covered:
• Kidneys
• Liver
• Lungs
• Heart
• Other Organs

End Users Covered:
• Organ Transplant Centers
• Hospitals
• Specialty Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

❖ レポートの目次 ❖

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Organ Preservation Solution Market, By Solution
5.1 Introduction
5.2 University of Wisconsin Solution (UW)
5.3 Custodiol HTK Solution
5.4 Perfadex Solution
5.5 Steen Solution
5.6 Celsior Solution
5.7 Hypothermosol Solution
5.8 Other Solutions

6 Global Organ Preservation Solution Market, By Preservation Type
6.1 Introduction
6.2 Static Cold Storage
6.3 Hypothermic Machine Perfusion
6.4 Normothermic Machine Perfusion
6.5 Other Preservation Types

7 Global Organ Preservation Solution Market, By Organ
7.1 Introduction
7.2 Kidneys
7.3 Liver
7.4 Lungs
7.5 Heart
7.6 Other Organs

8 Global Organ Preservation Solution Market, By End User
8.1 Introduction
8.2 Organ Transplant Centers
8.3 Hospitals
8.4 Specialty Clinics
8.5 Other End Users

9 Global Organ Preservation Solution Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Paragonix Technologies, Inc
11.2 Organox Limited
11.3 Transmedics, Inc.
11.4 Bridge to Life Ltd
11.5 Transplant Biomedicals
11.6 Accord Healthcare Inc.
11.7 Waters Medical Systems LLC
11.8 Preservation Solutions, Inc.
11.9 Xvivo Perfusion AB

List of Tables
Table 1 Global Organ Preservation Solution Market Outlook, By Region (2023–2034) ($MN)
Table 2 Global Organ Preservation Solution Market Outlook, By Solution (2023–2034) ($MN)
Table 3 Global Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2023–2034) ($MN)
Table 4 Global Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2023–2034) ($MN)
Table 5 Global Organ Preservation Solution Market Outlook, By Perfadex Solution (2023–2034) ($MN)
Table 6 Global Organ Preservation Solution Market Outlook, By Steen Solution (2023–2034) ($MN)
Table 7 Global Organ Preservation Solution Market Outlook, By Celsior Solution (2023–2034) ($MN)
Table 8 Global Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2023–2034) ($MN)
Table 9 Global Organ Preservation Solution Market Outlook, By Other Solutions (2023–2034) ($MN)
Table 10 Global Organ Preservation Solution Market Outlook, By Preservation Type (2023–2034) ($MN)
Table 11 Global Organ Preservation Solution Market Outlook, By Static Cold Storage (2023–2034) ($MN)
Table 12 Global Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2023–2034) ($MN)
Table 13 Global Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2023–2034) ($MN)
Table 14 Global Organ Preservation Solution Market Outlook, By Other Preservation Types (2023–2034) ($MN)
Table 15 Global Organ Preservation Solution Market Outlook, By Organ (2023–2034) ($MN)
Table 16 Global Organ Preservation Solution Market Outlook, By Kidneys (2023–2034) ($MN)
Table 17 Global Organ Preservation Solution Market Outlook, By Liver (2023–2034) ($MN)
Table 18 Global Organ Preservation Solution Market Outlook, By Lungs (2023–2034) ($MN)
Table 19 Global Organ Preservation Solution Market Outlook, By Heart (2023–2034) ($MN)
Table 20 Global Organ Preservation Solution Market Outlook, By Other Organs (2023–2034) ($MN)
Table 21 Global Organ Preservation Solution Market Outlook, By End User (2023–2034) ($MN)
Table 22 Global Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2023–2034) ($MN)
Table 23 Global Organ Preservation Solution Market Outlook, By Hospitals (2023–2034) ($MN)
Table 24 Global Organ Preservation Solution Market Outlook, By Specialty Clinics (2023–2034) ($MN)
Table 25 Global Organ Preservation Solution Market Outlook, By Other End Users (2023–2034) ($MN)
Table 26 North America Organ Preservation Solution Market Outlook, By Country (2023–2034) ($MN)
Table 27 North America Organ Preservation Solution Market Outlook, By Solution (2023–2034) ($MN)
Table 28 North America Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2023–2034) ($MN)
Table 29 North America Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2023–2034) ($MN)
Table 30 North America Organ Preservation Solution Market Outlook, By Perfadex Solution (2023–2034) ($MN)
Table 31 North America Organ Preservation Solution Market Outlook, By Steen Solution (2023–2034) ($MN)
Table 32 North America Organ Preservation Solution Market Outlook, By Celsior Solution (2023–2034) ($MN)
Table 33 North America Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2023–2034) ($MN)
Table 34 North America Organ Preservation Solution Market Outlook, By Other Solutions (2023–2034) ($MN)
Table 35 North America Organ Preservation Solution Market Outlook, By Preservation Type (2023–2034) ($MN)
Table 36 North America Organ Preservation Solution Market Outlook, By Static Cold Storage (2023–2034) ($MN)
Table 37 North America Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2023–2034) ($MN)
Table 38 North America Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2023–2034) ($MN)
Table 39 North America Organ Preservation Solution Market Outlook, By Other Preservation Types (2023–2034) ($MN)
Table 40 North America Organ Preservation Solution Market Outlook, By Organ (2023–2034) ($MN)
Table 41 North America Organ Preservation Solution Market Outlook, By Kidneys (2023–2034) ($MN)
Table 42 North America Organ Preservation Solution Market Outlook, By Liver (2023–2034) ($MN)
Table 43 North America Organ Preservation Solution Market Outlook, By Lungs (2023–2034) ($MN)
Table 44 North America Organ Preservation Solution Market Outlook, By Heart (2023–2034) ($MN)
Table 45 North America Organ Preservation Solution Market Outlook, By Other Organs (2023–2034) ($MN)
Table 46 North America Organ Preservation Solution Market Outlook, By End User (2023–2034) ($MN)
Table 47 North America Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2023–2034) ($MN)
Table 48 North America Organ Preservation Solution Market Outlook, By Hospitals (2023–2034) ($MN)
Table 49 North America Organ Preservation Solution Market Outlook, By Specialty Clinics (2023–2034) ($MN)
Table 50 North America Organ Preservation Solution Market Outlook, By Other End Users (2023–2034) ($MN)
Table 51 Europe Organ Preservation Solution Market Outlook, By Country (2023–2034) ($MN)
Table 52 Europe Organ Preservation Solution Market Outlook, By Solution (2023–2034) ($MN)
Table 53 Europe Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2023–2034) ($MN)
Table 54 Europe Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2023–2034) ($MN)
Table 55 Europe Organ Preservation Solution Market Outlook, By Perfadex Solution (2023–2034) ($MN)
Table 56 Europe Organ Preservation Solution Market Outlook, By Steen Solution (2023–2034) ($MN)
Table 57 Europe Organ Preservation Solution Market Outlook, By Celsior Solution (2023–2034) ($MN)
Table 58 Europe Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2023–2034) ($MN)
Table 59 Europe Organ Preservation Solution Market Outlook, By Other Solutions (2023–2034) ($MN)
Table 60 Europe Organ Preservation Solution Market Outlook, By Preservation Type (2023–2034) ($MN)
Table 61 Europe Organ Preservation Solution Market Outlook, By Static Cold Storage (2023–2034) ($MN)
Table 62 Europe Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2023–2034) ($MN)
Table 63 Europe Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2023–2034) ($MN)
Table 64 Europe Organ Preservation Solution Market Outlook, By Other Preservation Types (2023–2034) ($MN)
Table 65 Europe Organ Preservation Solution Market Outlook, By Organ (2023–2034) ($MN)
Table 66 Europe Organ Preservation Solution Market Outlook, By Kidneys (2023–2034) ($MN)
Table 67 Europe Organ Preservation Solution Market Outlook, By Liver (2023–2034) ($MN)
Table 68 Europe Organ Preservation Solution Market Outlook, By Lungs (2023–2034) ($MN)
Table 69 Europe Organ Preservation Solution Market Outlook, By Heart (2023–2034) ($MN)
Table 70 Europe Organ Preservation Solution Market Outlook, By Other Organs (2023–2034) ($MN)
Table 71 Europe Organ Preservation Solution Market Outlook, By End User (2023–2034) ($MN)
Table 72 Europe Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2023–2034) ($MN)
Table 73 Europe Organ Preservation Solution Market Outlook, By Hospitals (2023–2034) ($MN)
Table 74 Europe Organ Preservation Solution Market Outlook, By Specialty Clinics (2023–2034) ($MN)
Table 75 Europe Organ Preservation Solution Market Outlook, By Other End Users (2023–2034) ($MN)
Table 76 Asia Pacific Organ Preservation Solution Market Outlook, By Country (2023–2034) ($MN)
Table 77 Asia Pacific Organ Preservation Solution Market Outlook, By Solution (2023–2034) ($MN)
Table 78 Asia Pacific Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2023–2034) ($MN)
Table 79 Asia Pacific Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2023–2034) ($MN)
Table 80 Asia Pacific Organ Preservation Solution Market Outlook, By Perfadex Solution (2023–2034) ($MN)
Table 81 Asia Pacific Organ Preservation Solution Market Outlook, By Steen Solution (2023–2034) ($MN)
Table 82 Asia Pacific Organ Preservation Solution Market Outlook, By Celsior Solution (2023–2034) ($MN)
Table 83 Asia Pacific Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2023–2034) ($MN)
Table 84 Asia Pacific Organ Preservation Solution Market Outlook, By Other Solutions (2023–2034) ($MN)
Table 85 Asia Pacific Organ Preservation Solution Market Outlook, By Preservation Type (2023–2034) ($MN)
Table 86 Asia Pacific Organ Preservation Solution Market Outlook, By Static Cold Storage (2023–2034) ($MN)
Table 87 Asia Pacific Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2023–2034) ($MN)
Table 88 Asia Pacific Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2023–2034) ($MN)
Table 89 Asia Pacific Organ Preservation Solution Market Outlook, By Other Preservation Types (2023–2034) ($MN)
Table 90 Asia Pacific Organ Preservation Solution Market Outlook, By Organ (2023–2034) ($MN)
Table 91 Asia Pacific Organ Preservation Solution Market Outlook, By Kidneys (2023–2034) ($MN)
Table 92 Asia Pacific Organ Preservation Solution Market Outlook, By Liver (2023–2034) ($MN)
Table 93 Asia Pacific Organ Preservation Solution Market Outlook, By Lungs (2023–2034) ($MN)
Table 94 Asia Pacific Organ Preservation Solution Market Outlook, By Heart (2023–2034) ($MN)
Table 95 Asia Pacific Organ Preservation Solution Market Outlook, By Other Organs (2023–2034) ($MN)
Table 96 Asia Pacific Organ Preservation Solution Market Outlook, By End User (2023–2034) ($MN)
Table 97 Asia Pacific Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2023–2034) ($MN)
Table 98 Asia Pacific Organ Preservation Solution Market Outlook, By Hospitals (2023–2034) ($MN)
Table 99 Asia Pacific Organ Preservation Solution Market Outlook, By Specialty Clinics (2023–2034) ($MN)
Table 100 Asia Pacific Organ Preservation Solution Market Outlook, By Other End Users (2023–2034) ($MN)
Table 101 South America Organ Preservation Solution Market Outlook, By Country (2023–2034) ($MN)
Table 102 South America Organ Preservation Solution Market Outlook, By Solution (2023–2034) ($MN)
Table 103 South America Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2023–2034) ($MN)
Table 104 South America Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2023–2034) ($MN)
Table 105 South America Organ Preservation Solution Market Outlook, By Perfadex Solution (2023–2034) ($MN)
Table 106 South America Organ Preservation Solution Market Outlook, By Steen Solution (2023–2034) ($MN)
Table 107 South America Organ Preservation Solution Market Outlook, By Celsior Solution (2023–2034) ($MN)
Table 108 South America Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2023–2034) ($MN)
Table 109 South America Organ Preservation Solution Market Outlook, By Other Solutions (2023–2034) ($MN)
Table 110 South America Organ Preservation Solution Market Outlook, By Preservation Type (2023–2034) ($MN)
Table 111 South America Organ Preservation Solution Market Outlook, By Static Cold Storage (2023–2034) ($MN)
Table 112 South America Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2023–2034) ($MN)
Table 113 South America Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2023–2034) ($MN)
Table 114 South America Organ Preservation Solution Market Outlook, By Other Preservation Types (2023–2034) ($MN)
Table 115 South America Organ Preservation Solution Market Outlook, By Organ (2023–2034) ($MN)
Table 116 South America Organ Preservation Solution Market Outlook, By Kidneys (2023–2034) ($MN)
Table 117 South America Organ Preservation Solution Market Outlook, By Liver (2023–2034) ($MN)
Table 118 South America Organ Preservation Solution Market Outlook, By Lungs (2023–2034) ($MN)
Table 119 South America Organ Preservation Solution Market Outlook, By Heart (2023–2034) ($MN)
Table 120 South America Organ Preservation Solution Market Outlook, By Other Organs (2023–2034) ($MN)
Table 121 South America Organ Preservation Solution Market Outlook, By End User (2023–2034) ($MN)
Table 122 South America Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2023–2034) ($MN)
Table 123 South America Organ Preservation Solution Market Outlook, By Hospitals (2023–2034) ($MN)
Table 124 South America Organ Preservation Solution Market Outlook, By Specialty Clinics (2023–2034) ($MN)
Table 125 South America Organ Preservation Solution Market Outlook, By Other End Users (2023–2034) ($MN)
Table 126 Middle East & Africa Organ Preservation Solution Market Outlook, By Country (2023–2034) ($MN)
Table 127 Middle East & Africa Organ Preservation Solution Market Outlook, By Solution (2023–2034) ($MN)
Table 128 Middle East & Africa Organ Preservation Solution Market Outlook, By University of Wisconsin Solution (UW) (2023–2034) ($MN)
Table 129 Middle East & Africa Organ Preservation Solution Market Outlook, By Custodiol HTK Solution (2023–2034) ($MN)
Table 130 Middle East & Africa Organ Preservation Solution Market Outlook, By Perfadex Solution (2023–2034) ($MN)
Table 131 Middle East & Africa Organ Preservation Solution Market Outlook, By Steen Solution (2023–2034) ($MN)
Table 132 Middle East & Africa Organ Preservation Solution Market Outlook, By Celsior Solution (2023–2034) ($MN)
Table 133 Middle East & Africa Organ Preservation Solution Market Outlook, By Hypothermosol Solution (2023–2034) ($MN)
Table 134 Middle East & Africa Organ Preservation Solution Market Outlook, By Other Solutions (2023–2034) ($MN)
Table 135 Middle East & Africa Organ Preservation Solution Market Outlook, By Preservation Type (2023–2034) ($MN)
Table 136 Middle East & Africa Organ Preservation Solution Market Outlook, By Static Cold Storage (2023–2034) ($MN)
Table 137 Middle East & Africa Organ Preservation Solution Market Outlook, By Hypothermic Machine Perfusion (2023–2034) ($MN)
Table 138 Middle East & Africa Organ Preservation Solution Market Outlook, By Normothermic Machine Perfusion (2023–2034) ($MN)
Table 139 Middle East & Africa Organ Preservation Solution Market Outlook, By Other Preservation Types (2023–2034) ($MN)
Table 140 Middle East & Africa Organ Preservation Solution Market Outlook, By Organ (2023–2034) ($MN)
Table 141 Middle East & Africa Organ Preservation Solution Market Outlook, By Kidneys (2023–2034) ($MN)
Table 142 Middle East & Africa Organ Preservation Solution Market Outlook, By Liver (2023–2034) ($MN)
Table 143 Middle East & Africa Organ Preservation Solution Market Outlook, By Lungs (2023–2034) ($MN)
Table 144 Middle East & Africa Organ Preservation Solution Market Outlook, By Heart (2023–2034) ($MN)
Table 145 Middle East & Africa Organ Preservation Solution Market Outlook, By Other Organs (2023–2034) ($MN)
Table 146 Middle East & Africa Organ Preservation Solution Market Outlook, By End User (2023–2034) ($MN)
Table 147 Middle East & Africa Organ Preservation Solution Market Outlook, By Organ Transplant Centers (2023–2034) ($MN)
Table 148 Middle East & Africa Organ Preservation Solution Market Outlook, By Hospitals (2023–2034) ($MN)
Table 149 Middle East & Africa Organ Preservation Solution Market Outlook, By Specialty Clinics (2023–2034) ($MN)
Table 150 Middle East & Africa Organ Preservation Solution Market Outlook, By Other End Users (2023–2034) ($MN)



★調査レポート[世界の臓器保存液市場（～2030年）] (コード：SMRC24712)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の臓器保存液市場（～2030年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の臓器保存液市場
  • ビデオ管理システム（VMS）の世界市場（～2030年）
  • バスバーの世界市場（～2030年）
  • 自動車用ヒューズの世界市場（～2030年）
  • 世界の温度制御半導体チラー市場（～2030年）
  • リキッドバイオプシーの世界市場（～2030年）
  • 世界のRSウイルス（RSV）診断市場（2025年～2030年）
  • フラットガラスの世界市場（～2030年）
  • 空カプセルの世界市場（～2030年）
  • 世界の製造業における人工知能(AI)市場（～2030年）

    • ◆H&Iグローバルリサーチのお客様（例）◆